BIO summit outlines what industry needs for COVID-19 response
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BIO's virtual summit on biotech's response to the COVID-19 pandemic generated a wish list of resources to support development of therapeutics, vaccines and diagnostics, with appeals to both government agencies and industry peers.
The online meeting, which took place Tuesday and Wednesday, gathered representatives from 45 member companies developing products to take on COVID-19. Leading the discussion were Biotechnology Innovation Organization President and CEO Jim Greenwood and George Scangos, president and CEO of Vir Biotechnology Inc. (NASDAQ:VIR). ...